| Literature DB >> 32865022 |
Joshua M Kolz1, Scott A Mitchell1, Benjamin D Elder1, Arjun S Sebastian1, Paul M Huddleston1, Brett A Freedman1.
Abstract
STUDYEntities:
Keywords: ALIF; L4-S1; L5-S1; S1 fracture; osteoporosis
Year: 2020 PMID: 32865022 PMCID: PMC8907635 DOI: 10.1177/2192568220950332
Source DB: PubMed Journal: Global Spine J ISSN: 2192-5682
Figure 1.Patient 1: Preoperative lateral radiograph demonstrating lytic grade I spondylolisthesis (A). Lateral intraoperative radiograph following stage 1 ALIF using PEEK cage with anterior plating (B) and PSF instrumentation after the second stage (C). Postoperative CT scan demonstrating S1 insufficiency fracture (D) and 3 weeks postoperatively showing further subsidence of the ALIF cage (E). Lateral radiograph 6 months after revision L4-pelvis fusion (F).
Figure 2.Patient 2: Preoperative lateral radiograph demonstrating grade I degenerative spondylolisthesis (A) and postoperative radiograph following L5-S1 ALIF using PEEK cage with integrated fixation, and PSF (B). Postoperative day 53 CT scan demonstrating S1 insufficiency fracture (C) and postoperative radiograph 6 months after revision L4-pelvis fusion (D).
Figure 3.Patient 3: Preoperative lateral radiograph demonstrating grade II lytic spondylolisthesis (A) and postoperative radiograph following L5-S1 ALIF using PEEK cage with integrated fixation, and PSF (B). Postoperative day 114 CT scan demonstrating S1 insufficiency fracture (C) and postoperative radiograph 6 months after revision L4-pelvis fusion (D).
Figure 4.Patient 4: Preoperative lateral radiograph demonstrating grade I degenerative spondylolisthesis (A) and postoperative radiograph following L5-S1 ALIF with PEEK cage and integrated fixation (B). Postoperative day 17 CT scan demonstrating S1 insufficiency fracture (C) and postoperative radiograph 1 year after revision L5-S2AI fusion (D).
Figure 5.Patient 5: Preoperative lateral radiograph demonstrating grade I lytic spondylolisthesis (A) and postoperative radiograph following L5-S1 ALIF using femoral ring allograft with anterior plating (B). Postoperative day 31 CT scan demonstrating S1 insufficiency fracture and graft subsidence (C) and postoperative radiograph 1 year after revision L5-S2AI fusion (D).
Figure 6.Patient 6: CT scan demonstrating S1 insufficiency fracture after stand-alone ALIF using threaded titanium cage, completed at an outside institution 85 days earlier (A). Preoperative lateral radiograph demonstrating L4-L5 disc space collapse (B) and follow-up radiograph from 2.5 years after revision L5-S1 ALIF, L4-L5 ALIF, and L4-S1 PSF (C).
Patient Characteristics, Time to Fracture, and Treatment of Sacral Insufficiency Fractures After L5-S1 or L4-S1 Lumbosacral Fusion.
| Case | Age (years), sex | Previous lumbar surgery | Antecedent surgical levels | Procedure | Time to fracture (days) | Sacral fracture treatment | Bone mineral density | Past medical history | Reference article |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 60, male | None | L5-S1 | Staged ALIF (PEEK cage with anterior plating)/PSF | 1 | PSF L4-ilium | Osteopenia | COPD, DMII, HTN, OSA, morbid obesity | — |
| 2 | 76, male | None | L5-S1 | Staged ALIF (PEEK cage with integrated fixation)/PSF | 53 | PSF L4-ilium | Osteopenia | HTN, OSA | — |
| 3 | 66, male | None | L5-S1 | Staged ALIF (PEEK cage with integrated fixation)/PSF | 114 | PSF L4-ilium | Normal | DMII, CVA, PVD | — |
| 4 | 73, female | None | L5-S1 | ALIF (PEEK cage with integrated fixation) | 17 | PSF L5-S2AI | Osteopenia | HTN, HLD, DMII, hypothyroidism | — |
| 5 | 53, male | None | L5-S1 | ALIF (femoral ring allograft with anterior plating) | 31 | PSF L5-S2AI | Normal | Hypothyroidism | — |
| 6 | 31, female | None | L5-S1 | ALIF (titanium treaded cage) | 3 | L4-S1 ALIF/PSF | NA | Depression, chronic pain | — |
| 7 | 41, female | None | L4-S1 | PLIF | 3 months | PSF w/ sacral hooks | Normal | NA | Bose et al
|
| 8 | 39, male | None | L5-S1 | ALIF | 34 days | L5-S1 PSF | NA | NA | Lastfogel et al
|
| 9 | 36, male | None | L5-S1 | ALIF | 38 days | L5-S1 PSF | NA | NA | Lastfogel et al
|
| 10 | 48, male | None | L5-S1 | ALIF | 13 days | L5-S1 PSF | NA | NA | Lastfogel et al
|
| 11 | 72, male | None | L5-S1 | ALIF | 9 days | L5-S1 PSF | NA | NA | Phan et al
|
| 12 | 70, male | Decompression | L4-S1 | L4-S1 TLIF and PSF | 21 days | L4-ilium | Osteopenia | Pemphigus | Buell et al
|
| 13 | 66, male | None | L5-S1 | L5-S1 TLIF and PSF | 28 days | L4-ilium | Osteoporosis | COPD, smoker | Buell et al
|
| 14 | 76, female | None | L4-S1 | L4-S1 PSF | 21 days | L4-ilium | Osteoporosis | Hypothyroidism | Buell et al
|
| 15 | 69, female | None | L4-S1 | L4-S1 TLIF and PSF | 21 days | L4-ilium | Osteoporosis | Hyperparathyroidism, hypothyroidism, RA on prednisone | Buell et al
|
| 16 | 52, female | None | L4-S1 | L4-S1 PSF | Several months | L2-ilium | NA | NA | Hsieh et al
|
| 17 | 53, female | Decompression | L4-S1 | PSF/ALIF | 4 months | Brace therapy, osteoporosis tx | Osteoporosis | SLE, long-term prednisone | Elias et al
|
| 18 | 61, female | None | L5-S1 | PSF/PLIF | First few days | TLSO, osteoporosis tx | Osteopenia | Breast cancer s/p mastectomy, radiation, chemotherapy; neuromuscular scoliosis; polio | Fourney et al
|
| 19 | 57, female | None | L4-S1 | PSF | 2 months | Encouraged activity | NA | Morbid obesity, HTN, OSA | Khan et al
|
| 20 | 57, female | L5-S1 PLIF | L4-S1 | PSF | 6 weeks | Water therapy, pain control | NA | DMII, obesity | Khan et al
|
| 21 | 70, female | None | L4-S1 | PSF | 2 weeks | Conservative management | Osteoporosis | n/a | Mathews et al
|
| 22 | 57, female | None | L4-S1 | PSF/PLIF | 9 days | Short-period immobilization, orthotic | Osteoporosis | DMII, hepatitis C, COPD, long-term cortisone use | Pennekamp et al
|
Abbreviations: ALIF, anterior lumbar interbody fusion; PLIF, posterior lumbar interbody fusion; PSF, posterior spinal fusion; S2AI, s2 alar-iliac; HTN, hypertension; DMII, type II diabetes mellitus; OSA, obstructive sleep apnea; SLE, systemic lupus erythematous; COPD, chronic obstructive pulmonary disease.
Factors Predictive of the Need for Operative Intervention and Residual Pain at Final Follow-up.
| Odds ratio | 95% Confidence interval | ||
|---|---|---|---|
| Factors predictive of need for operative intervention | |||
| Women >50 years | NA | NA | |
| BMI >30 | 0.6 | 0.03-13.58 | |
| Stand-alone ALIF | NA | NA | |
| Male gender | NA | NA | |
| New radicular pain or neurologic deficit | 21.67 | 1.80-260.57 | |
| Factors predictive of residual pain | |||
| Operative intervention | 3 | 0.28-32.2 | |
| Women >50 years | 0.11 | 0.01-1.17 | |
| Male gender | 5 | 0.70-35.50 | |
| Fusion to pelvis | 0.86 | 0.14-5.22 | |
| BMI >30 | 1.67 | 0.07-37.7 | |
| New radicular pain or neurologic deficit | 5.25 | 0.50-54.91 |
Abbreviations: BMI, body mass index; ALIF, anterior lumbar interbody fusion.
a Women >50 years of age were less likely to require operative treatment.
*P value <.05.
Bone Mineral Density (BMD) Scores and Treatment of Bone Health for Patients With Sacral Insufficiency Fracture After Short-Segment Lumbosacral Fusion.
| Case | Age (years), sex | DEXA score and classification | Treatment for bone health |
|---|---|---|---|
| 1 | 60, male | −1.6 (osteopenia) | Referral to endocrine to begin treatment; however, patient died prior to starting medical treatment |
| 2 | 76, male | −2.2 (osteopenia) | Referral to endocrinology who started bisphosphonate treatment |
| 3 | 66, male | 0.1 (normal) | Normal BMD and therefore no treatment of BMD |
| 4 | 73, female | −1.5 (osteopenia) | Referral to endocrinology who continued to monitor her BMD and was treating with calcium and vitamin D supplementation |
| 5 | 53, male | −0.1 (normal) | Normal BMD and therefore no treatment of BMD |
| 6 | 31, female | NA | No DEXA scan was performed |